Gleostine (NextSource Biotechnology, LLC)
Welcome to the PulseAid listing for the Gleostine drug offered from NextSource Biotechnology, LLC. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | NextSource Biotechnology, LLC |
NON-PROPRIETARY NAME: | lomustine |
SUBSTANCE NAME: | LOMUSTINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, GELATIN COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2014-08-18 |
END MARKETING DATE: | 0000-00-00 |
Gleostine HUMAN PRESCRIPTION DRUG Details:
Item Description | Gleostine from NextSource Biotechnology, LLC |
LABELER NAME: | NextSource Biotechnology, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2014-08-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 58181-3040_43669261-fce0-45c0-a28a-4871c7d670d5 |
PRODUCT NDC: | 58181-3040 |
APPLICATION NUMBER: | NDA017588 |
Other LOMUSTINE Pharmaceutical Manufacturers / Labelers: